Personalized T cell therapy shows promise in stopping brain tumor growth

Brooks Hays
PHILADELPHIA, Feb. 18 (UPI) — Scientists have proven successful in engineering immune cells to track down and attack glioblastomas, the most common and aggressive type of brain tumor. —> Read More Here


Leave a Reply

Your email address will not be published. Required fields are marked *